Publications
2024
Human tetraspanin CD81 facilitates invasion of Salmonella enterica into human epithelial cells.
Vesicular Stomatitis Virus as a Platform for Protease Activity Measurements.
Terminal Ileitis as the Exclusive Manifestation of COVID-19 in Children.
Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster sera.
Machine Learning to Identify Critical Biomarker Profiles in New SARS-CoV-2 Variants.
Serine metabolism is crucial for cGAS-STING signaling and viral defense control in the gut.
Detection of infectious SARS-CoV-2 in ocular samples is linked to viral load in the nasopharynx.
Landscape of protein-protein interactions during hepatitis C virus assembly and release.
3D Spheroid and Organoid Models to Study Neuroinfection of RNA Viruses.
Identification of RVFV Host Factors Using Quantitative Interaction Proteomics.
2023
Antiviral Potential of Azelastine against Major Respiratory Viruses.
Efficient clathrin-mediated entry of enteric adenoviruses in human duodenal cells.
Genetic and pharmacological perturbation of hepatitis-C virus entry.
Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera.
Therapeutic Efficacy of a VSV-GP-based Human Papilloma Virus Vaccine in a Murine Cancer Model.
No evidence for epitranscriptomic m5C modification of SARS-CoV-2, HIV and MLV viral RNA.
Viral infection in chronic otitis media with effusion in children.
Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors.
Degradation of collagen I by activated C1s in periodontal Ehlers-Danlos Syndrome.
Reduced sensitivity of antibody tests after omicron infection.
2022
Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors.
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants.
Regimen of Coronavirus Disease 2019 Vaccination Influences Extent and Kinetics of Antibody Avidity.
miR-142 favors naïve B cell residence in peripheral lymph nodes.
Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases.
Development of a Rapid Live SARS-CoV-2 Neutralization Assay Based on a qPCR Readout.
The Tetraspanin CD81 Is a Host Factor for Chikungunya Virus Replication.
ADAM10 and ADAM17 promote SARS-CoV-2 cell entry and spike protein-mediated lung cell fusion.
Neutralization Profile after Recovery from SARS-CoV-2 Omicron Infection.
Persistence of humoral response upon SARS-CoV-2 infection.
SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons.
Impacts of rapid mass vaccination against SARS-CoV2 in an early variant of concern hotspot.
Congenital deficiency reveals critical role of ISG15 in skin homeostasis.
2021
Fluvastatin mitigates SARS-CoV-2 infection in human lung cells.
12-month SARS-CoV-2 antibody persistency in a Tyrolean COVID-19 cohort.
Characterization of RNA Sensing Pathways in Hepatoma Cell Lines and Primary Human Hepatocytes.
Heparan sulfate proteoglycans serve as alternative receptors for low affinity LCMV variants.
The Upper Respiratory Tract of Felids Is Highly Susceptible to SARS-CoV-2 Infection.
Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease.
Persistence of immunity to SARS-CoV-2 over time in the ski resort Ischgl.
The Phosphatidylserine Receptor TIM-1 Enhances Authentic Chikungunya Virus Cell Entry.
Interdependent Impact of Lipoprotein Receptors and Lipid-Lowering Drugs on HCV Infectivity.
6-month SARS-CoV-2 antibody persistency in a Tyrolian COVID-19 cohort.
Editorial: The Role of Complement in Microbial Infections.
Loss of the orphan nuclear receptor NR2F6 enhances CD8+ T-cell memory via IFN-γ.
High SARS-CoV-2 seroprevalence in children and adults in the Austrian ski resort of Ischgl.
Proximity labeling approaches to study protein complexes during virus infection.
2020
Comparison of Four SARS-CoV-2 Neutralization Assays.
A novel circulating tamiami mammarenavirus shows potential for zoonotic spillover.
Cholesterol sensing by CD81 is important for hepatitis C virus entry.
Liver-expressed Cd302 and Cr1l limit hepatitis C virus cross-species transmission to mice.
Interference of the Zika Virus E-Protein With the Membrane Attack Complex of the Complement System.
HPV-Induced Oropharyngeal Cancer and the Role of the E7 Oncoprotein Detection via Brush Test.
Single-nucleotide variants in human CD81 influence hepatitis C virus infection of hepatoma cells.
Post-Treatment HPV Surface Brushings and Risk of Relapse in Oropharyngeal Carcinoma.
2019
C1R Mutations Trigger Constitutive Complement 1 Activation in Periodontal Ehlers-Danlos Syndrome.
Viral Vectors for the Induction of Broadly Neutralizing Antibodies against HIV.
Measles Elimination: Identifying Susceptible Sub-Populations to Tailor Immunization Strategies.
RSV Vaccine Based on Rhabdoviral Vector Protects after Single Immunization.
Antibody opsonization enhances MAIT cell responsiveness to bacteria via a TNF-dependent mechanism.
Dynamic Dystroglycan Complexes Mediate Cell Entry of Lassa Virus.
2018
Active Human Complement Reduces the Zika Virus Load via Formation of the Membrane-Attack Complex.
Oncolytic activity of the rhabdovirus VSV-GP against prostate cancer.
Hepatitis C virus enters liver cells using the CD81 receptor complex proteins calpain-5 and CBLB.
Glycomics and Proteomics Approaches to Investigate Early Adenovirus-Host Cell Interactions.
The Oncolytic Virus VSV-GP Is Effective against Malignant Melanoma.
2017
Protein Interactions during the Flavivirus and Hepacivirus Life Cycle.
The Role of Type III Interferons in Hepatitis C Virus Infection and Therapy.
2016
Expanding the Host Range of Hepatitis C Virus through Viral Adaptation.
Decoding protein networks during virus entry by quantitative proteomics.
2015
A molecular tweezer antagonizes seminal amyloids and HIV infection.
Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice.
C peptides as entry inhibitors for gene therapy.
2014
A novel real-time CTL assay to measure designer T-cell function against HIV Env(+) cells.
Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1.
VSV-GP: a potent viral vaccine vector that boosts the immune response upon repeated applications.
The HCV life cycle: in vitro tissue culture systems and therapeutic targets.
2013
Inactivation of hepatitis C virus infectivity by human breast milk.
Mathematical modeling of oncogenesis control in mature T-cell populations.
Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines.
Mature T-cell lymphomagenesis induced by retroviral insertional activation of Janus kinase 1.
Stem cell clonality — theoretical concepts, experimental techniques, and clinical challenges.
Hepatitis C virus NS5B polymerase primes innate immune signaling.
A rationally engineered anti-HIV peptide fusion inhibitor with greatly reduced immunogenicity.
Opportunities and Risks of Host-targeting Antiviral Strategies for Hepatitis C.
2012
Comparison of three humanized mouse models for adoptive T cell transfer.
Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapy.
Inhibition of human immunodeficiency virus replication by cell membrane-crossing oligomers.
Specific acquisition of functional CD59 but not CD46 or CD55 by hepatitis C virus.
Targeting viral antigens to CD11c on dendritic cells induces retrovirus-specific T cell responses.
2011
Cancer suicide gene therapy with TK.007: superior killing efficiency and bystander effect.
Emerging role for complement in HIV infection.
Characterization of a canine homolog of hepatitis C virus.
Secreted antiviral entry inhibitory (SAVE) peptides for gene therapy of HIV infection.